Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$424.19
+4.7%
$402.59
$274.98
$643.48
$746.57M0.617,697 shs20,753 shs
Cerus Co. stock logo
CERS
Cerus
$1.66
-1.2%
$1.99
$1.21
$3.08
$300.93M1.291.51 million shs590,027 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$31.20
+1.9%
$28.26
$23.10
$53.50
$728.57M1.16182,206 shs83,481 shs
Pulmonx Co. stock logo
LUNG
Pulmonx
$7.52
+0.3%
$9.34
$7.21
$14.84
$289.82M0.6504,284 shs198,799 shs
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$17.57
-0.6%
$17.52
$6.08
$45.41
$688.22M1.48795,282 shs521,596 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
+4.66%+6.38%-2.93%+30.73%-34.08%
Cerus Co. stock logo
CERS
Cerus
-1.19%+1.22%-5.14%-9.78%-31.69%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
+1.86%+4.35%+19.04%+17.12%-36.93%
Pulmonx Co. stock logo
LUNG
Pulmonx
+0.27%+1.21%-15.79%-43.84%-35.73%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-0.57%+0.63%-4.67%+15.52%-60.51%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
1.5127 of 5 stars
0.01.02.50.02.23.31.3
Cerus Co. stock logo
CERS
Cerus
2.6491 of 5 stars
3.33.00.00.03.02.50.6
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
3.6699 of 5 stars
3.41.00.03.90.64.20.6
Pulmonx Co. stock logo
LUNG
Pulmonx
1.8838 of 5 stars
3.43.00.00.00.62.50.6
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
3.1832 of 5 stars
3.11.00.04.31.31.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/A
Cerus Co. stock logo
CERS
Cerus
2.67
Moderate Buy$3.50110.84% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.75
Moderate Buy$42.5036.22% Upside
Pulmonx Co. stock logo
LUNG
Pulmonx
2.83
Moderate Buy$15.83110.55% Upside
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
2.18
Hold$22.1826.25% Upside

Current Analyst Ratings

Latest ATRI, LUNG, CERS, KIDS, and SILK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/12/2024
Cerus Co. stock logo
CERS
Cerus
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$5.00
4/10/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00
4/3/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00
3/7/2024
Cerus Co. stock logo
CERS
Cerus
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$2.50
3/7/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$50.00
3/7/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00
3/6/2024
Cerus Co. stock logo
CERS
Cerus
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$3.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $23.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$10.00 ➝ $19.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$11.00 ➝ $18.00
2/23/2024
Pulmonx Co. stock logo
LUNG
Pulmonx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $17.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$169.33M4.41$20.80 per share20.39$138.02 per share3.07
Cerus Co. stock logo
CERS
Cerus
$156.37M1.92N/AN/A$0.29 per share5.72
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$148.73M4.99N/AN/A$16.14 per share1.93
Pulmonx Co. stock logo
LUNG
Pulmonx
$68.68M4.22N/AN/A$3.09 per share2.43
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$177.13M3.89N/AN/A$3.88 per share4.53

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$11.0338.46N/A11.46%8.07%7.37%5/13/2024 (Estimated)
Cerus Co. stock logo
CERS
Cerus
-$37.49M-$0.21N/AN/AN/A-23.98%-67.17%-17.68%5/2/2024 (Confirmed)
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$20.97M-$0.92N/AN/AN/A-14.10%-5.03%-4.37%5/6/2024 (Confirmed)
Pulmonx Co. stock logo
LUNG
Pulmonx
-$60.84M-$1.60N/AN/AN/A-88.60%-46.63%-32.14%5/1/2024 (Confirmed)
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$55.74M-$1.44N/AN/AN/A-31.70%-36.38%-21.41%4/30/2024 (Confirmed)

Latest ATRI, LUNG, CERS, KIDS, and SILK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.42N/A+$0.42N/AN/AN/A  
5/2/2024N/A
Cerus Co. stock logo
CERS
Cerus
-$0.04N/A+$0.04N/AN/AN/A  
5/1/2024N/A
Pulmonx Co. stock logo
LUNG
Pulmonx
-$0.43N/A+$0.43N/AN/AN/A  
4/30/2024N/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40N/A+$0.40N/AN/AN/A  
3/6/2024Q4 2023
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.28-$0.23+$0.05-$0.17$37.59 million$37.61 million
3/5/2024Q4 2023
Cerus Co. stock logo
CERS
Cerus
-$0.01-$0.01N/A-$0.01$46.80 million$46.77 million
2/29/2024Q4 2023
Atrion Co. stock logo
ATRI
Atrion
N/A$3.65+$3.65$3.65N/A$43.58 million
2/28/2024Q4 2023
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40-$0.33+$0.07-$0.33$42.23 million$47.27 million    
2/21/2024Q4 2023
Pulmonx Co. stock logo
LUNG
Pulmonx
-$0.38-$0.36+$0.02-$0.36$18.24 million$19.30 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.802.07%+9.65%79.78%21 Years
Cerus Co. stock logo
CERS
Cerus
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
Pulmonx Co. stock logo
LUNG
Pulmonx
N/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/AN/AN/AN/AN/A

Latest ATRI, LUNG, CERS, KIDS, and SILK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2024
Atrion Co. stock logo
ATRI
Atrion
Quarterly$2.202.42%3/14/20243/15/20243/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.09
2.57
Cerus Co. stock logo
CERS
Cerus
1.12
2.14
1.55
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.03
5.44
2.90
Pulmonx Co. stock logo
LUNG
Pulmonx
0.30
6.50
5.77
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.50
7.95
6.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Cerus Co. stock logo
CERS
Cerus
78.37%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
Pulmonx Co. stock logo
LUNG
Pulmonx
91.04%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/A

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.70%
Cerus Co. stock logo
CERS
Cerus
7.05%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
31.80%
Pulmonx Co. stock logo
LUNG
Pulmonx
5.70%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
6.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7121.76 million1.36 millionNot Optionable
Cerus Co. stock logo
CERS
Cerus
625181.28 million168.50 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
24723.79 million16.22 millionOptionable
Pulmonx Co. stock logo
LUNG
Pulmonx
27938.54 million36.34 millionOptionable
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
47439.17 million36.55 millionOptionable

ATRI, LUNG, CERS, KIDS, and SILK Headlines

SourceHeadline
Silk Road Medical to Present at the BofA Securities 2024 Healthcare ConferenceSilk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
globenewswire.com - April 23 at 4:30 PM
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to BuyAll You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
zacks.com - April 23 at 1:00 PM
Silk Road Medical (SILK) to Release Quarterly Earnings on TuesdaySilk Road Medical (SILK) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 23 at 4:32 AM
Silk Road Medical (SILK) to Release Earnings on TuesdaySilk Road Medical (SILK) to Release Earnings on Tuesday
marketbeat.com - April 23 at 4:30 AM
The Silk Road of the SeaThe Silk Road of the Sea
sundaytimes.lk - April 22 at 3:28 PM
Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.
nationalgeographic.com - April 22 at 3:28 PM
Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)
marketbeat.com - April 12 at 6:44 AM
Silk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from BrokeragesSilk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from Brokerages
marketbeat.com - April 12 at 2:17 AM
Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%
marketbeat.com - April 11 at 12:45 PM
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
globenewswire.com - April 9 at 4:30 PM
Silk Road Medicals (SILK) New Launch to Aid Its TCAR PortfolioSilk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
zacks.com - April 8 at 11:25 AM
China, Sri Lanka forging stronger bondsChina, Sri Lanka forging stronger bonds
chinadaily.com.cn - April 7 at 3:48 PM
Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%
marketbeat.com - April 5 at 3:45 PM
Taiwan Earthquake: What to Know About Travel and How to HelpTaiwan Earthquake: What to Know About Travel and How to Help
msn.com - April 5 at 1:08 AM
The One and Only Benedict WongThe One and Only Benedict Wong
vulture.com - April 4 at 7:57 AM
Silk Road Medical Launches Enroute Transcarotid NPS PlusSilk Road Medical Launches Enroute Transcarotid NPS Plus
evtoday.com - April 4 at 7:57 AM
Worker injured by electric shock from power line in BiddefordWorker injured by electric shock from power line in Biddeford
finance.yahoo.com - April 3 at 11:54 AM
Silk Road launches next-gen transcarotid neuroprotection systemSilk Road launches next-gen transcarotid neuroprotection system
massdevice.com - April 3 at 11:54 AM
Ancient People Also Had Sunburns, So They Used These 4 Forms of ProtectionAncient People Also Had Sunburns, So They Used These 4 Forms of Protection
msn.com - April 3 at 6:53 AM
Traditional Chinese medicine gains wider recognition around worldTraditional Chinese medicine gains wider recognition around world
sb.by - April 3 at 6:53 AM
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSSilk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
globenewswire.com - April 2 at 4:30 PM
Turkmenistan to launch traffic on Tejen - Mary expresswayTurkmenistan to launch traffic on Tejen - Mary expressway
en.trend.az - March 30 at 2:13 PM
Number of Russian Crocus City Hall terrorist attack victims increasesNumber of Russian Crocus City Hall terrorist attack victims increases
en.trend.az - March 30 at 2:13 PM
Rep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need A Global PerspectiveRep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need 'A Global Perspective'
theroot.com - March 29 at 2:31 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Atrion logo

Atrion

NASDAQ:ATRI
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Cerus logo

Cerus

NASDAQ:CERS
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.
OrthoPediatrics logo

OrthoPediatrics

NASDAQ:KIDS
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Pulmonx logo

Pulmonx

NASDAQ:LUNG
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Silk Road Medical logo

Silk Road Medical

NASDAQ:SILK
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.